Baker McKenzie advises ClinChoice on the acquisition of CROMSOURCE

Baker McKenzie advised ClinChoice Medical Development on the acquisition of CROMSOURCE S.r.l., an ISO-certified, full-service contract research organization with corporate headquarters in Verona, Italy and with operational subsidiaries in the US and seven countries throughout Western and Eastern Europe, along with field-based staff across various locations in Europe and across the US. Founded in 1997, CROMSOURCE has a proven track record of supporting global pharmaceutical, biotechnology and medical device clients with exceptional clinical research and staffing capabilities. 

Baker McKenzie assisted ClinChoice with a team led and coordinated by partner Marco Marazzi, assisted by senior associates Daniele Pitrolo, Arianna Ferri and Elisa Impalà, as well as counsel Antonio Lattanzio and associate Guido Pinto for regulatory aspects, and various professionals from seven other jurisdictions.

DLA Piper assisted Cromsource.

Grant Thornton assisted Clinchoice in the accounting/financial and tax aspects.